(2R)-2-[4-[2-(2-amino-[1,3]oxazolo[4,5-b]pyridin-5-yl)-9-oxa-1,3-diazatricyclo[6.5.1.04,14]tetradeca-2,4(14),5,7-tetraen-6-yl]pyrazol-1-yl]butanamide

C24H24N8O3 — CID 126673879

IUPAC(2R)-2-[4-[2-(2-amino-[1,3]oxazolo[4,5-b]pyridin-5-yl)-9-oxa-1,3-diazatricyclo[6.5.1.04,14]tetradeca-2,4(14),5,7-tetraen-6-yl]pyrazol-1-yl]butanamide
SMILESCC[C@H](C(N)=O)n1cc(-c2cc3c4c(c2)nc(-c2ccc5oc(N)nc5n2)n4CCCCO3)cn1
InChIInChI=1S/C24H24N8O3/c1-2-17(21(25)33)32-12-14(11-27-32)13-9-16-20-19(10-13)34-8-4-3-7-31(20)23(29-16)15-5-6-18-22(28-15)30-24(26)35-18/h5-6,9-12,17H,2-4,7-8H2,1H3,(H2,25,33)(H2,26,28,30)/t17-/m1/s1
InChIKeyZLEHWGCPYUIMLF-QGZVFWFLSA-N
MW472.51 g/mol
LogP3.29
Rot. Bonds5

About (2R)-2-[4-[2-(2-amino-[1,3]oxazolo[4,5-b]pyridin-5-yl)-9-oxa-1,3-diazatricyclo[6.5.1.04,14]tetradeca-2,4(14),5,7-tetraen-6-yl]pyrazol-1-yl]butanamide

(2R)-2-[4-[2-(2-amino-[1,3]oxazolo[4,5-b]pyridin-5-yl)-9-oxa-1,3-diazatricyclo[6.5.1.04,14]tetradeca-2,4(14),5,7-tetraen-6-yl]pyrazol-1-yl]butanamide (PubChem CID 126673879) has the molecular formula C24H24N8O3 and a molecular weight of 472.51 g/mol. Its IUPAC name is (2R)-2-[4-[2-(2-amino-[1,3]oxazolo[4,5-b]pyridin-5-yl)-9-oxa-1,3-diazatricyclo[6.5.1.04,14]tetradeca-2,4(14),5,7-tetraen-6-yl]pyrazol-1-yl]butanamide.

Molecular Properties

Compound Name(2R)-2-[4-[2-(2-amino-[1,3]oxazolo[4,5-b]pyridin-5-yl)-9-oxa-1,3-diazatricyclo[6.5.1.04,14]tetradeca-2,4(14),5,7-tetraen-6-yl]pyrazol-1-yl]butanamide
PubChem CID126673879
Molecular FormulaC24H24N8O3
Molecular Weight472.51 g/mol
Exact Mass472.20
IUPAC Name(2R)-2-[4-[2-(2-amino-[1,3]oxazolo[4,5-b]pyridin-5-yl)-9-oxa-1,3-diazatricyclo[6.5.1.04,14]tetradeca-2,4(14),5,7-tetraen-6-yl]pyrazol-1-yl]butanamide
SMILESCC[C@H](C(N)=O)n1cc(-c2cc3c4c(c2)nc(-c2ccc5oc(N)nc5n2)n4CCCCO3)cn1
InChIInChI=1S/C24H24N8O3/c1-2-17(21(25)33)32-12-14(11-27-32)13-9-16-20-19(10-13)34-8-4-3-7-31(20)23(29-16)15-5-6-18-22(28-15)30-24(26)35-18/h5-6,9-12,17H,2-4,7-8H2,1H3,(H2,25,33)(H2,26,28,30)/t17-/m1/s1
InChIKeyZLEHWGCPYUIMLF-QGZVFWFLSA-N
XLogP3.29
TPSA152.90 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds5
Heavy Atoms35
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500472.51
LogP ≤ 53.29
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Analyze (2R)-2-[4-[2-(2-amino-[1,3]oxazolo[4,5-b]pyridin-5-yl)-9-oxa-1,3-diazatricyclo[6.5.1.04,14]tetradeca-2,4(14),5,7-tetraen-6-yl]pyrazol-1-yl]butanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Diabzi sting agonist-1
CID 131986624
STING agonist-17
CID 164887458
(2S)-1-[2-(4-oxo-6,7-dihydropyrazolo[1,5-a]pyrazin-5-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide
CID 168293682
N-[3-({2-[(cyclopropylcarbonyl)amino][1,2,4]triazolo[1,5-a]pyridin-6-yl}oxy)-5-methylphenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide
CID 57749346
1-[4-(1,3-Benzoxazol-2-yl)piperidin-1-yl]-2-[4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]triazol-1-yl]ethanone
CID 59472771
1-[(E)-4-[5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-(3-morpholin-4-ylpropoxy)benzimidazole-5-carboxamide
CID 131986582
STING agonist-18
CID 132000129
benzyl N-[3-[5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-(3-morpholin-4-ylpropoxy)benzimidazol-1-yl]propyl]carbamate
CID 153623522
benzyl (3-(5-carbamoyl-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-7-(3-methoxypropoxy)-1H-benzo[d]imidazol-1-yl)propyl)carbamate
CID 155797702
STING agonist-20
CID 155787013
6-(1,2-Dimethylbenzimidazol-5-yl)-12-(1-methylpyrazol-4-yl)-3-[2-(oxolan-2-yl)ethyl]-8-oxa-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),5,10,12-pentaen-4-one
CID 71681410
2-[(2-Ethyl-5-methylpyrazole-3-carbonyl)amino]-7-(morpholin-4-ylmethoxy)-1-propylbenzimidazole-5-carboxamide
CID 162672630

Frequently Asked Questions

What is the IUPAC name of (2R)-2-[4-[2-(2-amino-[1,3]oxazolo[4,5-b]pyridin-5-yl)-9-oxa-1,3-diazatricyclo[6.5.1.04,14]tetradeca-2,4(14),5,7-tetraen-6-yl]pyrazol-1-yl]butanamide?
The IUPAC name of (2R)-2-[4-[2-(2-amino-[1,3]oxazolo[4,5-b]pyridin-5-yl)-9-oxa-1,3-diazatricyclo[6.5.1.04,14]tetradeca-2,4(14),5,7-tetraen-6-yl]pyrazol-1-yl]butanamide (CID 126673879) is (2R)-2-[4-[2-(2-amino-[1,3]oxazolo[4,5-b]pyridin-5-yl)-9-oxa-1,3-diazatricyclo[6.5.1.04,14]tetradeca-2,4(14),5,7-tetraen-6-yl]pyrazol-1-yl]butanamide.
What is the SMILES notation for (2R)-2-[4-[2-(2-amino-[1,3]oxazolo[4,5-b]pyridin-5-yl)-9-oxa-1,3-diazatricyclo[6.5.1.04,14]tetradeca-2,4(14),5,7-tetraen-6-yl]pyrazol-1-yl]butanamide?
The canonical SMILES for (2R)-2-[4-[2-(2-amino-[1,3]oxazolo[4,5-b]pyridin-5-yl)-9-oxa-1,3-diazatricyclo[6.5.1.04,14]tetradeca-2,4(14),5,7-tetraen-6-yl]pyrazol-1-yl]butanamide is CC[C@H](C(N)=O)n1cc(-c2cc3c4c(c2)nc(-c2ccc5oc(N)nc5n2)n4CCCCO3)cn1.
What is the InChIKey of (2R)-2-[4-[2-(2-amino-[1,3]oxazolo[4,5-b]pyridin-5-yl)-9-oxa-1,3-diazatricyclo[6.5.1.04,14]tetradeca-2,4(14),5,7-tetraen-6-yl]pyrazol-1-yl]butanamide?
The InChIKey is ZLEHWGCPYUIMLF-QGZVFWFLSA-N. The full InChI is InChI=1S/C24H24N8O3/c1-2-17(21(25)33)32-12-14(11-27-32)13-9-16-20-19(10-13)34-8-4-3-7-31(20)23(29-16)15-5-6-18-22(28-15)30-24(26)35-18/h5-6,9-12,17H,2-4,7-8H2,1H3,(H2,25,33)(H2,26,28,30)/t17-/m1/s1.
What are the key properties of (2R)-2-[4-[2-(2-amino-[1,3]oxazolo[4,5-b]pyridin-5-yl)-9-oxa-1,3-diazatricyclo[6.5.1.04,14]tetradeca-2,4(14),5,7-tetraen-6-yl]pyrazol-1-yl]butanamide?
(2R)-2-[4-[2-(2-amino-[1,3]oxazolo[4,5-b]pyridin-5-yl)-9-oxa-1,3-diazatricyclo[6.5.1.04,14]tetradeca-2,4(14),5,7-tetraen-6-yl]pyrazol-1-yl]butanamide has a molecular weight of 472.51 g/mol, XLogP of 3.29, 5 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-[4-[2-(2-amino-[1,3]oxazolo[4,5-b]pyridin-5-yl)-9-oxa-1,3-diazatricyclo[6.5.1.04,14]tetradeca-2,4(14),5,7-tetraen-6-yl]pyrazol-1-yl]butanamide is sourced from PubChem (CID 126673879), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).